Foghorn Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 02/17/2026 | 12.67 M | $68.44 M | 0.00% | 20.11% |
| FMR LLC | 02/17/2026 | 5.40 M | $29.14 M | -1.42% | 8.56% |
| BVF INC/IL | 02/17/2026 | 5.30 M | $28.63 M | 0.00% | 8.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 3.65 M | $19.71 M | 12.09% | 5.79% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 2.51 M | $13.53 M | 1.76% | 3.98% |
| BLACKROCK, INC. | 02/12/2026 | 2.35 M | $12.69 M | 3.98% | 3.73% |
| VANGUARD GROUP INC | 01/29/2026 | 1.93 M | $10.42 M | 1.55% | 3.06% |
| EUCLIDEAN CAPITAL LLC | 02/17/2026 | 1.57 M | $8.50 M | 0.00% | 2.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 795.04 K | $4.29 M | -1.66% | 1.26% |
| SIREN, L.L.C. | 02/13/2026 | 720.72 K | $3.89 M | 0.00% | 1.14% |
| STATE STREET CORP | 02/13/2026 | 618.67 K | $3.34 M | -2.90% | 0.98% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 607.67 K | $3.28 M | 100.00% | 0.96% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 297.74 K | $1.61 M | 151.82% | 0.47% |
| BIRCHVIEW CAPITAL, LP | 02/13/2026 | 281.73 K | $1.52 M | 0.00% | 0.45% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 269.19 K | $1.45 M | 46.25% | 0.43% |
| NORTHERN TRUST CORP | 02/17/2026 | 262.43 K | $1.42 M | -7.69% | 0.42% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 208.57 K | $1.13 M | 16.65% | 0.33% |
| CITADEL ADVISORS LLC | 02/17/2026 | 182.28 K | $984.29 K | 1,415.56% | 0.29% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 141.58 K | $764.53 K | 286.70% | 0.22% |
| JANE STREET GROUP, LLC | 02/12/2026 | 132.50 K | $715.51 K | 99.58% | 0.21% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 126.86 K | $685.04 K | 0.00% | 0.20% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 122.89 K | $663.60 K | 0.00% | 0.20% |
| MORGAN STANLEY | 02/13/2026 | 121.73 K | $657.33 K | 91.17% | 0.19% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 118.70 K | $640.99 K | 63.85% | 0.19% |
| SCS CAPITAL MANAGEMENT LLC | 02/10/2026 | 106.98 K | $577.69 K | 0.00% | 0.17% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 89.30 K | $482.19 K | 36.67% | 0.14% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 82.36 K | $444.76 K | -16.11% | 0.13% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 81.35 K | $439.28 K | 137.11% | 0.13% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 78.90 K | $426.05 K | -1.96% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 74.60 K | $402.84 K | 0.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 73.86 K | $398.84 K | 145.68% | 0.12% |
| BARCLAYS PLC | 02/13/2026 | 63.19 K | $341.23 K | 8.04% | 0.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 61.97 K | $334.63 K | -83.30% | 0.10% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 53.26 K | $287.59 K | 100.00% | 0.08% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/17/2026 | 53.14 K | $286.98 K | -25.82% | 0.08% |
| NUVEEN, LLC | 02/12/2026 | 50.13 K | $270.72 K | 0.00% | 0.08% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 47.11 K | $254.38 K | 311.75% | 0.07% |
| RHUMBLINE ADVISERS | 02/13/2026 | 40.12 K | $216.63 K | -8.25% | 0.06% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 38.76 K | $209.28 K | 58.35% | 0.06% |
| DIADEMA PARTNERS LP | 02/17/2026 | 30.63 K | $165.40 K | -38.74% | 0.05% |
| MARSHALL WACE, LLP | 02/13/2026 | 28.89 K | $156.02 K | 100.00% | 0.05% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 27.42 K | $148.07 K | 7.28% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 26.66 K | $143.96 K | 0.00% | 0.04% |
| UBS GROUP AG | 01/29/2026 | 24.51 K | $132.33 K | -29.67% | 0.04% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 24.13 K | $130.30 K | 100.00% | 0.04% |
| WOODLINE PARTNERS LP | 02/17/2026 | 21.52 K | $116.22 K | -80.18% | 0.03% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 19.14 K | $103.37 K | -10.05% | 0.03% |
| JPMORGAN CHASE & CO | 02/11/2026 | 17.22 K | $92.98 K | 4.70% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 16.60 K | $89.64 K | 100.00% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 16.41 K | $89.00 K | 0.00% | 0.03% |
Foghorn Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 121 institutional investors and hedge funds held shares of Foghorn Therapeutics Inc. The most heavily invested institutionals were:
Candriam S.C.A.: 313,765
VANGUARD FIDUCIARY TRUST CO: 240,586
SCS Capital Management LLC: 106,980
Bank of New York Mellon Corp: 79,559
UBS Group AG: 75,835
Nuveen, LLC: 50,378
66.44% of Foghorn Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 46.49 M shares in the last 24 months. This purchase volume represents approximately $254.76 M in transactions.